Grants and Contributions:

Title:
E!6384 MIDOSC: MetaOptima and Isla collaboration for the Detection and triage of Skin Cancer
Agreement Number:
1020995
Agreement Value:
$500,000.00
Agreement Date:
Aug 1, 2024 - Jul 31, 2026
Description:
As part of the international consortium project E!6384 MIDOSC, this project will focus on low-cost AI-assisted software product to manage the skin-cancer patient pathways within the NHS (National Health and Safety) in the UK.
Organization:
National Research Council Canada
Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:
Vancouver, British Columbia, CA V6E 4E6
Reference Number:
172-2024-2025-Q2-1020995
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
842173536
Recipient Type:
For-profit organization
Recipient's Operating Name:
MetaOptima
Recipient's Legal Name:
MetaOptima Technology Inc.
Federal Riding Name:
Vancouver Centre
Federal Riding Number:
59034
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
33451